T0	UnderpoweredStudy 27012 27116	the overall cure rate achieved in this trial was much lower at 14% with a 0.65% difference in cure rates
T1	FollowUpDuration 27156 27297	a six month follow-up is a more realistic time point at which to assess the success of treatments of cutaneous warts than shorter time frames
T2	ActivePlacebo 28087 28117	the lack of a no treatment arm
T3	Intervention 28328 28441	we collected patient self reported data on adherence to treatment only at one and three weeks after randomisation
T4	Intervention 28775 28817	a lower adherence for the treatment period
T5	NonstandardTreatmentCharacteristics 30285 30392	Nor did we evaluate the effectiveness of salicylic acid treatment if delivered by a healthcare professional
